Skip to main content
. 2013 Jan 7;9(3):712–719. doi: 10.4161/hv.23270

Table 2. Risk factors for IPD according to serotype.

       Serotype 1 (n = 62)
     %
     Others (n = 231) %      aOR
     (95% CI)a
     Serotype 19A (n = 47)
     %
     Others (n = 246) %      aOR
     (95%CI)a
     Serotype 3 (n = 37)
     %
     Others (n = 256) %      aOR
     (95%CI)a
     Serotype 7F (n = 20)
     %
     Others (n = 273) %      aOR
     (95% CI)a
     Sex-male      54.8      53.7      1.23
     (0.65 – 2.34)
     59.6      52.8      1.53
     (0.73 – 3.22)
     43.2      55.5      0.58
     (0.28 – 1.21)
     75.0      52.4      2.53
     (0.88 – 7.28)
     Age                        
     3–23 mo      8.1      47.6      Reference      70.2      33.3      Reference      43.2      38.7      Reference      50.0      38.5      Reference
     24–59 mo      91.9      52.4      7.70
     (2.70 – 21.98)
     29.8      66.7      0.19
     (0.09 – 0.41)
     56.8      61.3      1.11
     (0.45 – 2.73)
     50.0      61.5      0.79
     (0.27 – 2.34)
     Vaccination status                        
     Non vaccinated      37.1      49.4      Reference      57.4      44.7      Reference      24.3      50.0      Reference      40.0      47.3      Reference
     Vaccinated      53.2      43.3      1.14
     (0.57 – 2.31)
     40.4      46.3      0.61
     (0.30 – 1.27)
     73.0      41.4      4.87
     (2.05 – 11.59)
     55.0      44.7      1.69
     (0.64 – 4.51)
     Day care or school attendance      93.3      78.1      3.55
     (1.21 – 10.38)
     75.0      82.5      0.86
     (0.35 – 2.12)
     74.3      82.3      0.42
     (0.17 – 1.01)
     75.0      81.8      0.94
     (0.26 – 3.27)
     Antibiotic treatment      6.6      16.4      0.37
     (0.12 – 1.16)
     22.7      12.8      1.96
     (0.76 – 5.03)
     11.4      14.7      0.81
     (0.24 – 2.75)
     15.0      14.3      0.79
     (0.20 – 3.12)
     Respiratory infection      41.0      49.6      1.09
     (0.46 – 2.90)
     65.1      44.6      2.26
     (1.03 – 4.94)
     37.1      49.2      0.65
     (0.29 – 1.48)
     50.0      47.5      1.04
     (0.38 – 2.85)
     Breastfeeding      6.5      10.4      0.95
     (0.28 – 3.14)
     14.9      8.5      1.24
     (0.41 – 3.69)
     8.1      9.8      0.59
     (0.14 – 2.43)
     5.0      9.9      0.29
     (0.03 – 2.50)
     Exposure to tobacco in home                        
     0 cigarettes/d      63.3      58.6      Reference      72.1      57.4      Reference      62.9      59.2      Reference      52.6      60.8      Reference
     1–19 cigarettes/d      13.3      10.3      1.30
     (0.40 – 4.24)
     16.3      19.8      0.70
     (0.27 – 1.81)
     17.1      19.6      0.83
     (0.30 – 2.26)
     26.3      18.8      1.73
     (0.53 – 5.70)
     ≥ 20 cigarettes/d      23.3      20.5      0.77
     (0.34 – 1.73)
     11.6      22.8      0.41
     (0.14 – 1.22)
     20.0      21.2      1.04
     (0.40 – 2.71)
     21.1      21.1      1.29
     (0.37 – 4.50)
     Cohabitants > 4 persons      23.3      24.8      1.33
     (0.59 – 3.01)
     16.3      25.9      0.46
     (0.18 – 1.20)
     19.4      25.2      0.76
     (0.28 – 2.07)
     35.0      23.7      1.62
     (0.57 – 4.62)
     Siblings < 5 y      30.0      30.6      1.17
     (0.58 – 2.35)
     23.3      31.8      0.65
     (0.28 – 1.52)
     30.6      30.5      0.95
     (0.42 – 2.15)
     30.0      30.5      0.81
     (0.29 – 2.25)
     Social class                        
     I-III      69.6      56.9      Reference      56.1      60.3      Reference      63.6      59.0      Reference      52.6      60.2      Reference
     IV-V      30.4      43.1      0.76
     (0.36 – 1.57)
     43.9      39.7      1.23
     (0.56 – 2.71)
     36.4      41.0      1.06
     (0.47 – 2.39)
     47.4      39.8      1.34
     (0.50 – 3.55)
     Intensive care unit      3.2      16.9      0.13
     (0.02 – 1.03)
     19.1      13.0      0.85
     (0.34 – 2.12)
     16.2      13.7      1.38
     (0.50 – 3.82)
     25.0      13.2      1.68
     (0.50 – 5.65)
     Non-penicillin susceptibleb      0.0      46.0      —      60.0      25.9      1.89
     (1.13 – 3.16)
     16.7      35.8      0.71
     (0.22 – 2.38)
     0.0      38.1      —
     Death      0.0      1.3      —      0.0      1.2      —      0.0      1.2      —      5.0      0.7      3.20
     (0.20 – 51.19)
     Risk medical conditions      0.0      1.7      —      0.0      1.6      —      0.0      1.6      —      0.0      1.5      —

Notes: aAdjusted for age, vaccination with ≥ 1 dose of PCV7, attending day care or school, antibiotics prescribed within 30 d before the onset of clinical symptoms and previous respiratory infection. bAntibiogram was performed in cases diagnosed by culture (n = 115). Abbreviations: y, year; m, months; d, days; OR, odds ratio; aOR, adjusted odds ratio; IPD, invasive pneumococcal disease.